Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics

References

• Harvey C. (2005). Wound healing. Orthop Nurs, 24:143–57.
   PubMed Web of Science ®Google Scholar
• Suh H. (2000). Tissue restoration, tissue engineering and regenerative medicine. Yonsei Med J, 41:681–4.
   PubMed Web of Science ®Google Scholar
• Kumar R, Dutt K. (2006). Enhanced neurotrophin synthesis and molecular differentiation in non-transformed human retinal progenitor cells cultured in a rotating bioreactor. Tissue Eng, 12:141–58.
   PubMedGoogle Scholar
• Chayed S, Winnik FM. (2007). In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur J Pharm Biopharm, 65:363–70.
   PubMed Web of Science ®Google Scholar
• Hussein MZ, Nasir NM, Yahaya AH. (2008). Controlled release compound based on metanilate-layered double hydroxide nanohybrid. J Nanosci Nanotechnol, 8:5921–8.
   PubMed Web of Science ®Google Scholar
• Kim SS, Min SP, Oju J, Cha YC, Kim BS. (2006). Poly(lactide-c­o-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials, 27:1399–409.
   PubMed Web of Science ®Google Scholar
• Young S, Wong M, Tabata Y, Mikos AG. (2005). Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release, 109:256–74.
   PubMed Web of Science ®Google Scholar
• Stenekes RJH, Loebis AE, Fernandes CM, Crommelin DJA, Hennink WE. (2001). Degradable dextran microspheres for the controlled release of liposomes. Int J Pharm, 214:17–20.
   PubMed Web of Science ®Google Scholar
• Kim IS, Jeong YI, Kim DH, Lee YH, Kim SH. (2001). Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer. Arch Pharm Res, 24:69–73.
   PubMed Web of Science ®Google Scholar
• van Dijk-Wolthuis WNE, Franssen O, Talsma H, van Steenbergen MJ, Kettenes-van den Bosch JJ, Hennink WE. (1995). Synthesis, characterization and polymerization of glycidyl methacrylate derivatized dextran. Macromolecules, 28:6317–22.
   Web of Science ®Google Scholar
• Cadée JA, de Groot CJ, Jiskoot W, den Otter W, Hennink WE. (2002). Release of recombinant human interleukin-2 from d­extran-based hydrogels. J Control Release, 78:1–13.
   PubMed Web of Science ®Google Scholar
• Chen FM, Zhao YM, Wu H, Deng ZH, Wang QT, Zhou W, et al. (2006). Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran–co-gelatin microspheres. J Control Release, 114:209–22.
   PubMed Web of Science ®Google Scholar
• Chen FM, Wu ZF, Sun HH, Wu H, Xin SN, Wang QT, et al. (2006). Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept. Int J Pharm, 307:23–32.
   PubMed Web of Science ®Google Scholar
• Chen FM, Ma ZW, Dong GY, Wu ZF. (2009). Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery. Acta Pharmacol Sin, 23:1–9.
   Google Scholar
• Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55:329–47.
   PubMed Web of Science ®Google Scholar
• Biondi M, Ungaro F, Quaglia F, Netti PA. (2008). Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev, 60:229–42.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 125:193–209.
   PubMed Web of Science ®Google Scholar
• Jabr-Milane L, van Vlerken L, Devalapally H, Shenoy D, Komareddy S, Bhavsar M. (2008). Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release, 130:121–8.
   PubMed Web of Science ®Google Scholar
• Kosmala JD, Henthorn DB, Brannon-Peppas L. (2000). Preparation of interpenetrating networks of gelatin and dextran as degradable biomaterials. Biomaterials, 21:2019–23.
   PubMed Web of Science ®Google Scholar
• Tang MH, Dou HJ, Sun K. (2006). One-step synthesis of d­extran-based stable nanoparticles assisted by self-assembly. P­olymer, 47:728–34.
   Web of Science ®Google Scholar
• Zhang H, Gu CH, Wu H, Fan L, Li F, Yang F, et al. (2007). Im­mobilization of derivatized dextran nanoparticles on konjac glucomannan/chitosan film as a novel wound dressing. Biofactors, 30:227–40.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Ikada Y, Tabata Y. (2001). Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed, 12:77–88.
   PubMed Web of Science ®Google Scholar
• Kopen C, Prockop DJ, Phinney DG. (1999). Marrow stromal cells migrates throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA, 96:10711–6.
   PubMed Web of Science ®Google Scholar
• Landegren U. (1984). Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods, 67:379–88.
   PubMed Web of Science ®Google Scholar
• Kim SH, Chu CC. (2000). Synthesis and characterization of dextran methacrylate hydrogels and structural study by SEM. J Biomed Mater Res, 49:517–27.
   PubMed Web of Science ®Google Scholar
• Reilly GC, Radin S, Chen AT, Ducheyne P. (2007). Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials, 28:4091–7.
   PubMed Web of Science ®Google Scholar
• Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest, 103:697–705.
   PubMed Web of Science ®Google Scholar
• Shi X, Sitharaman B, Pham QP, Liang F, Wu K, Edward Billups W, et al. (2007). Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials, 28:4078–90.
   PubMed Web of Science ®Google Scholar
• Gospodarowizc N. (1991). Biological activities of fibroblast growth factor. Ann N Y Acad Sci, 638:1–8.
   Web of Science ®Google Scholar
• McGee GS, Cavidson JM, Buckley A, Sommer A, Woodward SC, Aquino AM. (1988). Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res, 45:145–53.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E. (1994). Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology, 135:774–81.
   PubMed Web of Science ®Google Scholar
• Trippel SB. (1995). Growth factor actions on articular cartilage. J Rheumatol Suppl, 22:129–32.
   Google Scholar
• Chan D, Lamande SR, Cole WG, Bateman JF. (1990). Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J, 269:175–81.
   PubMed Web of Science ®Google Scholar
• McCarthy JB, Vachhani B, Iida J. (1996). Cell adhesion to c­ollagenous matrices. Biopolymers, 40:371–81.
   PubMed Web of Science ®Google Scholar
• Eyre DR, Wu JJ, Fernandes RJ, Pietka TA, Weis MA. (2002). Recent developments in cartilage research: Matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans, 30:893–9.
   PubMedGoogle Scholar
• Nagai T, Yamakawa N, Aota S, Yamada SS, Akiyama SK, Olden K, et al. (1991). Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol, 114:1295–305.
   PubMed Web of Science ®Google Scholar
• Akiyama SK, Yamada KM, Hayashi M. (1981). The structure of fibronectin and its role in cellular adhesion. J Supramol Struct Cell Biochem, 16:345–8.
   PubMedGoogle Scholar